Fuji Health Science, Burlington, NJ, has concluded a marketing agreement with Sanat Products Ltd, India involving the strategic placement of spirulina products within the North American market. Both companies are involved in the cultivation of microalgae for natural human health benefits. Fuji is a leader in the production of natural astaxanthin from the single cell microalgae, Haematococcus pluvialis, and Sanat is a major producer of organic spirulina.